Skip to main content

Media Kit

About the remedē® System

The remedē System is a breakthrough implantable system that safely and effectively treats moderate to severe Central Sleep Apnea (CSA) in adult patients. CSA is a serious breathing disorder that disrupts the normal breathing pattern during sleep and has been shown to negatively impact quality of life and heart health.1

In a clinical study, the remedē System has been shown to improve sleep, oxygen levels and enhance overall quality of life:

  • 88% of patients had a reduction in Apnea-Hypopnea Index, an indication of CSA severity2,3
  • 78% of patients had an improvement in quality of life3
  • 90% of patients were free from serious adverse events related to the implant procedure, the device, or delivered therapy at 12 months2
Media Contact

Seamus Jackson
Vice President of Global Marketing

The remedē® System Clinical Trial News Releases